Molecular epidemiology of Acinetobacter baumannii bloodstream isolates obtained in the United States from 1995 to 2004 using rep-PCR and multilocus sequence typing

Journal of Clinical Microbiology

Volumn 50, Issue 11, 2012, Pages 3493-3500

  Higgins, Paul G ^a   Janeßn, Katharina ^a   Fresen, Maximilian M ^a   Wisplinghoff, Hilmar ^a   Seifert, Harald ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; CARBAPENEMASE; DOXYCYCLINE; IMIPENEM; LEVOFLOXACIN; SULTAMICILLIN;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ACINETOBACTER NOSOCOMIALIS; ACINETOBACTER PITTII; ANALYTICAL EQUIPMENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL TRANSMISSION; BACTERIUM DETECTION; BACTERIUM ISOLATE; BLA OXA 51 GENE; BLOODSTREAM INFECTION; CLONAL SPECIES; CONTROLLED STUDY; DISEASE SURVEILLANCE; GENE INSERTION SEQUENCE; GENETIC VARIABILITY; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; INTERMETHOD COMPARISON; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; MULTILOCUS SEQUENCE TYPING; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REPETITIVE SEQUENCE BASED POLYMERASE CHAIN REACTION; UNITED STATES;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; BACTEREMIA; CLUSTER ANALYSIS; GENOTYPE; HOSPITALS; HUMANS; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; POLYMERASE CHAIN REACTION; UNITED STATES;

EID: 84867612746     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01759-12     Document Type: Article

References (36)

1. Adams-Haduch JM, et al. 2011. Molecular epidemiology of carbapenemnonsusceptible Acinetobacter baumannii in the United States. J. Clin. Microbiol. 49:3849 -3854.
2. Bartual SG, et al. 2005. Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J. Clin. Microbiol. 43:4382- 4390.
3. Behringer M, Miller WG, Oyarzabal OA. 2011. Typing of Campylobacter jejuni and Campylobacter coli isolated from live broilers and retail broiler meat by flaA-RFLP, MLST, PFGE and REP-PCR. J. Microbiol. Methods 84:194 -201.
4. Ben-Darif E, et al. 2010. Comparison of a semi-automated rep-PCR system and multilocus sequence typing for differentiation of Salmonella enterica isolates. J. Microbiol. Methods 81:11-16.
5. Clinical and Laboratory Standards Institute. 2011. Performance standards for antimicrobial susceptibility testing; Twenty-first informational supplement. CLSI Document M100-S21. Clinical and Laboratory Standards Institute, Wayne, PA.
6. Cofsky R, et al. 2002. The cost of antibiotic resistance: effect of resistance among Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa on length of hospital stay. Infect. Control Hosp. Epidemiol. 23:106-108. (Pubitemid 34205646)
7. Corvec S, et al. 2003. AmpC cephalosporinase hyperproduction in Acinetobacter baumannii clinical strains. J. Antimicrob. Chemother. 52:629-635. (Pubitemid 37258424)
8. Davies TA, et al. 2011. Longitudinal survey of carbapenem resistance and resistance mechanisms in Enterobacteriaceae and non-fermenters from the U. S. A. in 2007-2009. J. Antimicrob. Chemother. 66:2298 -2307.
9. Diancourt L, Passet V, Nemec A, Dijkshoorn L, Brisse S. 2010. The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS One 5:e10034. doi:10.1371/journal.pone.0010034.
10. Dijkshoorn L, et al. 1996. Comparison of outbreak and nonoutbreak Acinetobacter baumannii strains by genotypic and phenotypic methods. J. Clin. Microbiol. 34:1519 -1525.
11. Dijkshoorn L, Nemec A, Seifert H. 2007. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat. Rev. Microbiol. 5:939 -951.
12. He C, et al. 2011. Increasing imipenem resistance and dissemination of the ISAba1-associated bla(OXA-23) gene among Acinetobacter baumannii isolates in an intensive care unit. J. Med. Microbiol. 60:337-341.
13. Healy M, et al. 2005. Microbial DNA typing by automated repetitive-sequence-based PCR. J. Clin. Microbiol. 43:199 -207.
14. Higgins PG, Dammhayn C, Hackel M, Seifert H. 2010. Global spread of carbapenem-resistant Acinetobacter baumannii. J. Antimicrob. Chemother. 65:233-238.
15. Higgins PG, Hujer AM, Hujer KM, Bonomo RA, Seifert H. 2012. Interlaboratory reproducibility of DiversiLab rep-PCR typing and clustering of Acinetobacter baumannii isolates. J. Med. Microbiol. 61:137-141.
16. Higgins PG, Lehmann M, Seifert H. 2010. Inclusion of OXA-143 primers in a multiplex polymerase chain reaction (PCR) for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int. J. Antimicrob. Agents 35:305.
17. Kohlenberg A, et al. 2009. Outbreak of carbapenem-resistant Acinetobacter baumannii carrying the carbapenemase OXA-23 in a German university medical centre. J. Med. Microbiol. 58:1499 -1507.
18. Krizova L, Nemec A. 2010. A 63 kb genomic resistance island found in a multidrug-resistant Acinetobacter baumannii isolate of European clone I from 1977. J. Antimicrob. Chemother. 65:1915-1918.
19. Lee Y, et al. 2011. Carbapenem-non-susceptible Acinetobacter baumannii of sequence type 92 or its single-locus variants with a G428T substitution in zone 2 of the rpoB gene. J. Antimicrob. Chemother. 66:66-72.
20. Nemec A, et al. 2011. Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. nov. (formerly Acinetobacter genomic species 3) and Acinetobacter nosocomialis sp. nov. (formerly Acinetobacter genomic species 13TU). Res. Microbiol. 162:393- 404.
21. Peleg AY, Seifert H, Paterson DL. 2008. Acinetobacter baumannii: emergence of a successful pathogen. Clin. Microbiol. Rev. 21:538 -582.
22. Poirel L, Nordmann P. 2006. Genetic structures at the origin of acquisition and expression of the carbapenem-hydrolyzing oxacillinase gene bla(OXA-58) in Acinetobacter baumannii. Antimicrob. Agents Chemother. 50:1442-1448.
23. Runnegar N, et al. 2010. Molecular epidemiology of multidrug-resistant Acinetobacter baumannii in a single institution over a 10-year period. J. Clin. Microbiol. 48:4051- 4056.
24. Saeed S, Fakih MG, Riederer K, Shah AR, Khatib R. 2006. Interinstitutional and intrainstitutional transmission of a strain of Acinetobacter baumannii detected by molecular analysis: comparison of pulsed-field gel electrophoresis and repetitive sequence-based polymerase chain reaction. Infect. Control Hosp. Epidemiol. 27:981-983. (Pubitemid 44449261)
25. Seifert H, et al. 2005. Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii. J. Clin. Microbiol. 43:4328-4335. (Pubitemid 41298209)
26. Seifert H, Schulze A, Baginski R, Pulverer G. 1994. Plasmid DNA-fingerprinting of Acinetobacter species other than Acinetobacter baumannii. J. Clin. Microbiol. 32:82- 86.
27. Snitkin ES, et al. 2011. Genome-wide recombination drives diversification of epidemic strains of Acinetobacter baumannii. Proc. Natl. Acad. Sci. U. S. A. 108:13758 -13763.
28. Spence RP, et al. 2002. Population structure and antibiotic resistance of Acinetobacter DNA group 2 and 13TU isolates from hospitals in the UK. J. Med. Microbiol. 51:1107-1112. (Pubitemid 36020733)
29. Te Witt R, Kanhai V, van Leeuwen WB. 2009. Comparison of the DiversiLab (TM) system, pulsed-field gel electrophoresis and multi-locus sequence typing for the characterization of epidemic reference MRSA strains. J. Microbiol. Methods 77:130 -133.
30. Traub WH, Bauer D. 2000. Surveillance of nosocomial cross-infections due to three Acinetobacter genospecies (Acinetobacter baumannii, genospecies 3 and genospecies 13) during a 10-year observation period: serotyping, macrorestriction analysis of genomic DNA and antibiotic susceptibilities. Chemotherapy 46:282-292. (Pubitemid 30428842)
31. Turton JF, et al. 2006. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol. Lett. 258:72-77.
32. van Dessel H, et al. 2004. Identification of a new geographically widespread multiresistant Acinetobacter baumannii clone from European hospitals. Res. Microbiol. 155:105-112.
33. Wisplinghoff H, et al. 2004. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39:309 -317.
34. Wisplinghoff H, et al. 2008. Molecular epidemiology of clinical Acinetobacter baumannii and Acinetobacter genomic species 13TU isolates using a multilocus sequencing typing scheme. Clin. Microbiol. Infect. 14:708-715. (Pubitemid 351837032)
35. Wisplinghoff H, et al. 2012. Nosocomial bloodstream infections due to Acinetobacter baumannii, Acinetobacter pittii and Acinetobacter nosocomialis in the United States. J. Infect. 64:282-290.
36. Woodford N, et al. 2006. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int. J. Antimicrob. Agents 27:351-353.